Latest perspectives on the benefits of neoadjuvant therapy for patients with advanced gastric cancer

Q4 Medicine Libri Oncologici Pub Date : 2023-06-27 DOI:10.20471/lo.2023.51.01.04
Tea Budija, J. Marić-Brozić
{"title":"Latest perspectives on the benefits of neoadjuvant therapy for patients with advanced gastric cancer","authors":"Tea Budija, J. Marić-Brozić","doi":"10.20471/lo.2023.51.01.04","DOIUrl":null,"url":null,"abstract":"Treatment for gastric cancer has multiple approaches and options across the world. Standard treatment for the Asian population comprises D2-gastrectomy and adjuvant chemotherapy. However, in Europe and North America, clinical trials have shown that perioperative chemotherapy, given to patients before surgery, could improve resection and survival rates significantly. Most recent studies have also discussed the advantages of doublet vs. triplet chemotherapy regimens. Furthermore, researchers have been comparing the effects of perioperative chemoradiotherapy as opposed to chemotherapy alone. The specific advantages of previously stated therapy options, as well as any novel treatments, should be researched more thoroughly in the future.","PeriodicalId":53700,"journal":{"name":"Libri Oncologici","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Libri Oncologici","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20471/lo.2023.51.01.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Treatment for gastric cancer has multiple approaches and options across the world. Standard treatment for the Asian population comprises D2-gastrectomy and adjuvant chemotherapy. However, in Europe and North America, clinical trials have shown that perioperative chemotherapy, given to patients before surgery, could improve resection and survival rates significantly. Most recent studies have also discussed the advantages of doublet vs. triplet chemotherapy regimens. Furthermore, researchers have been comparing the effects of perioperative chemoradiotherapy as opposed to chemotherapy alone. The specific advantages of previously stated therapy options, as well as any novel treatments, should be researched more thoroughly in the future.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症晚期新辅助治疗的最新进展
在世界范围内,胃癌的治疗有多种方法和选择。亚洲人群的标准治疗包括d2胃切除术和辅助化疗。然而,在欧洲和北美,临床试验表明,在手术前给予患者围手术期化疗可以显著提高切除率和生存率。最近的大多数研究也讨论了双重化疗方案与三重化疗方案的优势。此外,研究人员一直在比较围手术期放化疗与单独化疗的效果。在未来,应该更彻底地研究先前陈述的治疗方案的具体优势,以及任何新的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Libri Oncologici
Libri Oncologici Medicine-Oncology
CiteScore
0.30
自引率
0.00%
发文量
9
审稿时长
8 weeks
期刊介绍: - Genitourinary cancer: the potential role of imaging - Hemoglobin level and neoadjuvant chemoradiation in patients with locally advanced cervical carcinoma
期刊最新文献
Results of multicenter testing of PIK3CA somatic mutations in hormone-receptor positive HER2-negative advanced breast cancer Use of nasolabial flap for reconstruction of the floor of the mouth defects Hereditary breast and ovarian cancer – University Hospital of Split experiences Breast cancer radiotherapy - changes in fractionation schemes through decades Latest perspectives on the benefits of neoadjuvant therapy for patients with advanced gastric cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1